< back to main site

Publications

Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency

Kry, S F; Lye, J; Clark, C H; Andratschke, N; Dimitiadis, A; Followill, D; Howell, R; Hussein, M; Ishikawa, M; Kito, S; Kron, T; Lee, J; Michalski, J; Monti, A F; Reynaert, N; Taylor, P; Venables, K; Xiao, Y; Lehmann, J (2021) Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency. Radiotherapy and Oncology, 159. pp. 106-111.

[thumbnail of eid9398.pdf]
Preview
Text
eid9398.pdf - Published Version
Available under License Creative Commons Attribution.

Download (928kB) | Preview
Item Type: Article
Subjects: Ionising Radiation > Dosimetry
Divisions: Medical, Marine & Nuclear
Identification number/DOI: 10.1016/j.radonc.2021.03.006
Last Modified: 25 Mar 2022 14:58
URI: https://eprintspublications.npl.co.uk/id/eprint/9398
View Item